Ulrike Litzenburger

发表

Single-cell chromatin accessibility reveals principles of regulatory variation

Howard Y. Chang, Jason D. Buenrostro, M. Snyder, 2015, Nature.

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

M. Weller, W. Wick, D. Schrenk, 2011, Nature.

ATAC-see reveals the accessible genome by transposase-mediated imaging and sequencing

Howard Y. Chang, Jason D. Buenrostro, Ansuman T. Satpathy, 2016, Nature Methods.

Joint single-cell DNA accessibility and protein epitope profiling reveals environmental regulation of epigenomic heterogeneity

Howard Y. Chang, Alicia N. Schep, W. Greenleaf, 2018, Nature Communications.

Single-cell epigenomic variability reveals functional cancer heterogeneity

Nathan C. Sheffield, Howard Y. Chang, William J. Greenleaf, 2017, Genome Biology.

The Indoleamine-2,3-Dioxygenase (IDO) Inhibitor 1-Methyl-D-tryptophan Upregulates IDO1 in Human Cancer Cells

W. Wick, Ulrike Litzenburger, F. Sahm, 2011, PloS one.

CELL BIOLOGY AND SIGNALING

V. P. Collins, Michael A. Koldobskiy, R. Spang, 2010 .

Acetate supplementation restores chromatin accessibility and promotes tumor cell differentiation under hypoxia

Howard Y. Chang, J. Maris, A. Giaccia, 2020, Cell Death & Disease.

Integrative profiling of early host chromatin accessibility responses in human neutrophils with sensitive pathogen detection

Steven B. Cogill, Howard Y. Chang, Nikhil Ram-Mohan, 2020, bioRxiv.

Abstract: ATAC-seq Reveals Heterogeneity of Fibroblasts During Transition from Scarless Fetal to Scar-Forming Adult Wound Repair

Howard Y. Chang, I. Weissman, Rahul Sinha, 2016, Plastic and Reconstructive Surgery Global Open.

Suppression of human CD4+ T cell activation by 3,4-dimethoxycinnamonyl-anthranilic acid (tranilast) is mediated by CXCL9 and CXCL10.

W. Wick, T. Serafini, Ulrike Litzenburger, 2011, Biochemical pharmacology.

An endogenous ligand of the human aryl hydrocarbon receptor promotes tumor formation

I. Lehman, M. Weller, W. Wick, 2017 .

The aryl hydrocarbon receptor in tumor immunity

W. Wick, Ulrike Litzenburger, M. Plattén, 2012, Oncoimmunology.

Invariant Natural Killer T Cell Subsets Have Diverse Graft-Versus-Host-Disease-Preventing and Anti-Tumor Effects.

Howard Y. Chang, Ulrike Litzenburger, A. Bhatt, 2021, Blood.

Invariant natural killer T-cell subsets have diverse graft-versus-host-disease – preventing and antitumor effects

Howard Y. Chang, Ulrike Litzenburger, A. Bhatt, 2021 .

Promotion of Glioblastoma Cell Motility by Enhancer of Zeste Homolog 2 (EZH2) Is Mediated by AXL Receptor Kinase

A. von Deimling, W. Wick, C. Hartmann, 2012, PloS one.

Toll‐Like Receptor Engagement Enhances the Immunosuppressive Properties of Human Bone Marrow‐Derived Mesenchymal Stem Cells by Inducing Indoleamine‐2,3‐dioxygenase‐1 via Interferon‐β and Protein Kinase R

M. Weller, W. Wick, Ulrike Litzenburger, 2009, Stem cells.

Protein kinase Cβ as a therapeutic target stabilizing blood–brain barrier disruption in experimental autoimmune encephalomyelitis

A. von Deimling, W. Wick, S. Meuth, 2013, Proceedings of the National Academy of Sciences.

The autism risk factor CHD8 is a chromatin activator in human neurons and functionally dependent on the ERK-MAPK pathway effector ELK1

Howard Y. Chang, Pedro J. Batista, T. Südhof, 2021, Scientific Reports.

The Autism Risk Factor CHD8 Is a Chromatin Activator and Functionally Dependent on the ERK-MAPK Pathway Effector ELK1

Howard Y. Chang, Pedro J. Batista, T. Südhof, 2020, bioRxiv.

Joint single-cell DNA accessibility and protein epitope profiling reveals environmental regulation of epigenomic heterogeneity

Howard Y. Chang, Alicia N. Schep, W. Greenleaf, 2018, bioRxiv.

Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR

A. von Deimling, W. Wick, T. Höfer, 2014, Oncotarget.

Prrx1 Fibroblasts Represent a Pro-fibrotic Lineage in the Mouse Ventral Dermis

Howard Y. Chang, Deshka S. Foster, S. Adem, 2020, Cell reports.

Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma

Jessica M. Rusert, Joshua E. Elias, M. Scott, 2018, Science Signaling.

Suppression of TDO‐mediated tryptophan catabolism in glioblastoma cells by a steroid‐responsive FKBP52‐dependent pathway

A. von Deimling, W. Wick, Ulrike Litzenburger, 2015, Glia.

Profiling chromatin accessibility responses in human neutrophils with sensitive pathogen detection

Steven B. Cogill, Howard Y. Chang, Ulrike Litzenburger, 2021, Life Science Alliance.

Single-cell lineage tracing by endogenous mutations enriched in transposase accessible mitochondrial DNA

Howard Y. Chang, R. Majeti, M. Corces, 2018, bioRxiv.

Anendogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

M. Weller, W. Wick, D. Schrenk, 2011 .

Acetate supplementation restores chromatin accessibility and promotes tumor cell differentiation under hypoxia

Howard Y. Chang, J. Maris, A. Giaccia, 2020, Cell Death and Disease.

ATAC-see reveals the accessible genome by transposase-mediated imaging and sequencing

Howard Y. Chang, Jason D. Buenrostro, Ansuman T. Satpathy, 2016, Nature Methods.

Suppression of TDO‐mediated tryptophan catabolism in glioblastoma cells by a steroid‐responsive FKBP52‐dependent pathway

A. von Deimling, W. Wick, Ulrike Litzenburger, 2015, Glia.

ATAC Primer Tool for targeted analysis of accessible chromatin

Howard Y. Chang, Ava C. Carter, Ulrike Litzenburger, 2018, Nature Methods.